医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
LXEO · Lexeo Therapeutics, Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Lexeo Therapeutics, Inc.（LXEO）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $300K；高管董事有效买入 —、有效卖出 —。最近申报 2026-08-19。
买入 Bought—
卖出 Sold$300K
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-08-18 | Townsend Richard Nolan Chief Executive Officer, Director | 卖出 Sell | 3,345 | $4.95 | $17K | SEC |
| 2026-08-18 | Otero Jose Manuel Chief Operating Officer | 卖出 Sell | 1,304 | $4.96 | $6K | SEC |
| 2026-08-18 | Tamayo Louis Edward Chief Financial Officer | 卖出 Sell | 4,117 | $4.91 | $20K | SEC |
| 2026-07-01 | Bhalla Narinder Pal Chief Medical Officer | 卖出 Sell | 22,306 | $4.42 | $99K | SEC |
| 2026-07-01 | Townsend Richard Nolan Chief Executive Officer, Director | 卖出 Sell | 25,947 | $4.48 | $116K | SEC |
| 2026-07-01 | Otero Jose Manuel Chief Operating Officer | 卖出 Sell | 4,666 | $4.48 | $21K | SEC |
| 2026-07-01 | Tamayo Louis Edward Chief Financial Officer | 卖出 Sell | 4,641 | $4.49 | $21K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-08-18 | Tamayo Louis Edward Officer | 4,117 | $20K | |
| 2026-08-18 | Townsend Richard Nolan Officer, Director | 3,345 | $17K | |
| 2026-08-18 | Otero Jose Manuel Officer | 1,304 | $6K | |
| 2026-07-01 | Townsend Richard Nolan Officer, Director | 25,947 | $116K | |
| 2026-07-01 | Bhalla Narinder Pal Officer | 22,306 | $99K | |
| 2026-07-01 | Otero Jose Manuel Officer | 4,666 | $21K | |
| 2026-07-01 | Tamayo Louis Edward Officer | 4,641 | $21K |
内部人 Insiders
Townsend Richard Nolan、Otero Jose Manuel、Tamayo Louis Edward、Bhalla Narinder Pal